𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lipids, lipoproteins, and coronary heart disease: Implications for antihypertensive therapy

✍ Scribed by M. D. Feher; D. J. Betteridge


Publisher
Springer US
Year
1989
Tongue
English
Weight
628 KB
Volume
3
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.

✦ Synopsis


There is now considerable evidence that treatment of abnormalities of lipids and lipoproteins reduces the incidence of coronary heart disease (CHD). Treatment of hypertension, another major cardiovascular risk factor, has not been shown to have the same impact on CHD. Possible explanations for this are that cardiovascular risk factors may occur in combination in an individual or that therapy for hypertension has adversely affected one or several of the other risk factors for CHD, thereby offsetting the benefit gained by lowering blood pressure.

This article reviews the relationship between lipids, lipoproteins, and coronary heart disease, and the impact of cholesterol lowering on CHD. The evidence that antihypertensive drugs are associated with lipid and lipoprotein abnormalities is introduced by a critical appraisal of the several studies for such evidence. Implications for the treatment of the hypertensive patient are discussed.


πŸ“œ SIMILAR VOLUMES


Microchip-based small, dense low-density
✍ Hua Wang; Hui-Min Wang; Qing-Hui Jin; Hui Cong; Gui-Sheng Zhuang; Jian-Long Zhao πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 494 KB

## Abstract Small, dense low‐density lipoprotein (sdLDL) has been accepted as an emerging cardiovascular risk factor, and there has been an increasing interest in analytical methods for sdLDL profiling for diagnosis. Serum sdLDL may be measured by different laboratory techniques, but all these meth

Effects of Ava II and Hinc II polymorphi
✍ Luis A. Salazar; Mario H. Hirata; SΓ©rgio D. Giannini; Neusa Forti; Jayme Diament πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 62 KB πŸ‘ 2 views

Coronary heart disease (CHD) has presented high prevalence in the Brazilian population. Nevertheless, studies of genetic risk factors for CHD in our country are insufficiently carried out. We have investigated the effects of Ava II (exon 13) and Hinc II (exon 12) polymorphisms at the low-density lip